Australian Clinical Labs (ASX:ACL) Price-to-Tangible-Book : (As of Jun. 06, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Price-to-Tangible-Book?

As of today (2024-06-06), Australian Clinical Labs's share price is A$2.29. Australian Clinical Labs's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$-0.00. Hence, Australian Clinical Labs's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Australian Clinical Labs's Price-to-Tangible-Book or its related term are showing as below:

During the past 4 years, Australian Clinical Labs's highest Price to Tangible Book Ratio was 95.56. The lowest was 13.83. And the median was 45.67.

ASX:ACL's Price-to-Tangible-Book is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 2.535
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Australian Clinical Labs's share price is A$2.29. Australian Clinical Labs's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.82. Hence, Australian Clinical Labs's P/B Ratio of today is 2.79.

Australian Clinical Labs Price-to-Tangible-Book Historical Data

The historical data trend for Australian Clinical Labs's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Price-to-Tangible-Book Chart

Australian Clinical Labs Annual Data

Trend

Dec20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

13.83

95.56

Australian Clinical Labs Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial			29.25	13.83	62.08	95.56	-

Competitive Comparison of Australian Clinical Labs's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, Australian Clinical Labs's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Australian Clinical Labs's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Australian Clinical Labs's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Australian Clinical Labs's Price-to-Tangible-Book falls into.

Australian Clinical Labs Price-to-Tangible-Book Calculation

Australian Clinical Labs's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	2.29	/	-0.001
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Australian Clinical Labs Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168

Website

https://www.clinicallabs.com.au

Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines